ClinicalTrialsFinder

Biliary Tract or Colorectal Cancer With Her2-positive/Mutated Clinical Trials in Guangzhou

1 recruitingGuangzhou, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.

Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
Shanghai Pharmaceuticals Holding Co., Ltd60 enrolled30 locationsNCT06434597